Subviral Particles: Prions and Viroids (2B)

The discovery of conventional viruses in the late nineteenth and early twentieth centuries initially seemed to establish the smallest possible infectious agents: entities composed of a nucleic acid genome enclosed within a protein capsid. However, several mysterious diseases—among them scrapie in sheep and potato spindle tuber disease in plants—resisted explanation by any known viral, bacterial, or fungal pathogen. These enigmatic conditions pointed toward a class of infectious agents smaller and fundamentally simpler than viruses, entities that would eventually be termed subviral particles. The elucidation of prions and viroids constituted a paradigm shift in molecular biology, forcing researchers to reconsider the minimal requirements for infectivity and the mechanisms by which disease can propagate in the absence of a conventional genome.

The central question that these discoveries raised—and that remains a high-yield conceptual framework for the MCAT—is: What is the minimal molecular architecture required for an infectious agent, and how can disease propagate without nucleic acid replication (prions) or without any protein component (viroids)? These entities exist at the very boundary of life and non-life, and understanding them is essential for grasping how cellular organization can be subverted by remarkably simple molecular agents.

Subviral particles are infectious agents simpler than conventional viruses. While viruses themselves are already acellular and obligate intracellular parasites, subviral particles lack one or more of the defining features of a complete virus—namely, they may lack either a protein coat (viroids) or a nucleic acid genome (prions). Understanding these entities requires a firm grasp of how they differ from viruses and from one another, as the MCAT frequently tests the ability to distinguish among viruses, viroids, prions, and satellites.

The diagram above captures the fundamental mechanism of prion disease at the molecular level. The normal cellular prion protein, PrPᶜ, is a glycosylphosphatidylinositol (GPI)-anchored glycoprotein expressed on the surface of neurons and other cell types, with a secondary structure dominated by α-helices. When PrPᶜ encounters the misfolded isoform PrPˢᶜ—whether through exogenous exposure (infection), sporadic misfolding, or germline mutation in the PRNP gene—a conformational change is induced. The resulting PrPˢᶜ has a markedly increased β-sheet content, rendering it resistant to protease digestion, detergent solubilization, and standard autoclaving procedures. Critically, this process operates without any nucleic acid template; the "information" that is transmitted is purely structural, encoded in the three-dimensional conformation of the protein.

Prion Propagation: The Nucleation-Polymerization Model

Two major models have been proposed for prion propagation, and the nucleation-polymerization model has gained the most experimental support. In this framework, PrPᶜ and PrPˢᶜ exist in a thermodynamic equilibrium that heavily favors PrPᶜ under normal conditions. Spontaneous conversion of individual PrPᶜ monomers to PrPˢᶜ is extremely rare and thermodynamically unfavorable. However, once a critical "seed" or oligomeric nucleus of PrPˢᶜ forms, it stabilizes the misfolded conformation cooperatively. Additional PrPᶜ molecules are then recruited to the growing aggregate, undergo conformational conversion upon joining the fibril, and the aggregate elongates. Fragmentation of fibrils generates new seeds, creating a positive feedback loop that underlies the exponential kinetics of prion amplification. This explains the characteristically long incubation periods of prion diseases followed by rapid neurodegeneration once a threshold aggregate burden is reached.

Viroid Replication: Rolling Circle Mechanism

Viroid replication proceeds through a rolling circle mechanism that differs between the two viroid families. Members of the Pospiviroidae (e.g., PSTVd) replicate in the host cell nucleus using an asymmetric rolling circle pathway. The circular (+) RNA is transcribed by host DNA-dependent RNA polymerase II—remarkably, this polymerase normally transcribes DNA templates, yet viroids have evolved RNA structures that mimic promoter elements sufficiently to commandeer this enzyme. The polymerase generates a linear, multimeric (−) strand, which then serves as a template for (+) strand synthesis. The multimeric (+) strand is processed into unit-length molecules by host RNase III, and the linear monomers are circularized by host DNA ligase I. Members of the Avsunviroidae (e.g., avocado sunblotch viroid, ASBVd) replicate in the chloroplast via a symmetric rolling circle pathway in which both (+) and (−) strands serve as templates. Crucially, Avsunviroidae members possess hammerhead ribozyme motifs that catalyze self-cleavage of multimeric replication intermediates, a process that does not require any protein enzyme—a finding with profound implications for the RNA world hypothesis.

Several distinctions in this table are particularly high-yield for the MCAT. First, prions are uniquely resistant to standard decontamination procedures precisely because they contain no nucleic acid to denature and their β-sheet-rich aggregates are thermodynamically very stable. Second, viroids infect only plants—this is a commonly tested fact that distinguishes them from viruses and prions. Third, the immune system mounts a minimal response to prions because PrPˢᶜ shares the same primary amino acid sequence as the host's own PrPᶜ; the immune system recognizes it as "self," which is one reason prion diseases are invariably fatal once clinical symptoms appear.

The following worked example simulates an MCAT-style passage analysis in which you must integrate molecular biology knowledge of prions with clinical reasoning. Such passage-based reasoning questions are increasingly common on the exam and require you to apply core principles to novel experimental contexts.

Prion diseases present unique diagnostic and therapeutic challenges. Because PrPˢᶜ shares its primary sequence with the host's own PrPᶜ, the immune system fails to mount an effective response—there are no antibodies, no T-cell activation against the infectious agent. This immunological "silence" means that prion diseases are invariably fatal, with no effective treatment currently available. Diagnostic confirmation typically requires neuropathological examination at autopsy, though advances in real-time quaking-induced conversion (RT-QuIC) assays now allow antemortem detection of prion seeding activity in cerebrospinal fluid. Viroid diseases, while devastating to agricultural productivity—PSTVd can reduce potato yields by up to 65%—do not affect animals or humans and thus represent a different category of concern, primarily economic rather than medical.

The study of subviral particles connects to several advanced concepts that extend well beyond the immediate scope of prion and viroid biology. From an evolutionary perspective, viroids are considered possible relics of the RNA world—a hypothetical stage in early Earth's history when RNA molecules served simultaneously as genetic material and as catalysts (ribozymes). The hammerhead ribozyme motifs found in Avsunviroidae may represent surviving vestiges of this ancient RNA-based biology. Prion biology, meanwhile, has intersected with the study of neurodegenerative diseases more broadly: the concept of "prion-like" propagation has been extended to aggregated forms of tau (in Alzheimer's disease), α-synuclein (in Parkinson's disease), and TDP-43 (in ALS/frontotemporal dementia), in which misfolded proteins spread between cells and template the misfolding of their normal counterparts in a stereotyped, seed-dependent manner.

For the MCAT, the most critical forward-looking connections involve understanding how prions and viroids challenge canonical molecular biology frameworks. You should be prepared to recognize experimental designs that differentiate between nucleic-acid-based and protein-based infectious agents (as in the worked example), and to reason about how protein misfolding can propagate pathology through conformational templating rather than genetic replication.